Davion Healthcare acquires Humaskan Medical Technology intellectual property for $25M
Davion Healthcare (DAVI) announced Monday that it has completed the acquisition of the intellectual property relating to two medical technologies WoundSkan and the Spektra Lateral Flow Test for $25M from the four shareholders of Humaskan.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.